- Home
- DSWL vs CUE Comparison
DSWL vs CUE Comparison
Compare DSWL & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSWL
- CUE
- Stock Information
- Founded
- DSWL 1987
- CUE 2014
- Country
- DSWL Macau
- CUE United States
- Employees
- DSWL N/A
- CUE N/A
- Industry
- DSWL Plastic Products
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- DSWL Industrials
- CUE Health Care
- Exchange
- DSWL Nasdaq
- CUE Nasdaq
- Market Cap
- DSWL 64.1M
- CUE 59.5M
- IPO Year
- DSWL 1995
- CUE 2018
- Fundamental
- Price
- DSWL $4.03
- CUE $0.73
- Analyst Decision
- DSWL
- CUE Strong Buy
- Analyst Count
- DSWL 0
- CUE 2
- Target Price
- DSWL N/A
- CUE $3.00
- AVG Volume (30 Days)
- DSWL 43.3K
- CUE 132.9K
- Earning Date
- DSWL 11-14-2025
- CUE 11-13-2025
- Dividend Yield
- DSWL 4.95%
- CUE N/A
- EPS Growth
- DSWL 45.62
- CUE N/A
- EPS
- DSWL 0.70
- CUE N/A
- Revenue
- DSWL $67,610,000.00
- CUE $8,286,000.00
- Revenue This Year
- DSWL N/A
- CUE N/A
- Revenue Next Year
- DSWL N/A
- CUE $13.27
- P/E Ratio
- DSWL $5.67
- CUE N/A
- Revenue Growth
- DSWL N/A
- CUE N/A
- 52 Week Low
- DSWL $1.93
- CUE $0.45
- 52 Week High
- DSWL $4.48
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- DSWL 58.98
- CUE 37.43
- Support Level
- DSWL $3.80
- CUE $0.71
- Resistance Level
- DSWL $4.40
- CUE $0.78
- Average True Range (ATR)
- DSWL 0.21
- CUE 0.03
- MACD
- DSWL -0.05
- CUE -0.01
- Stochastic Oscillator
- DSWL 37.50
- CUE 20.10
About DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.